En esta página
TRVI Trevi Therapeutics, Inc. - Common Stock
NASDAQ · Pharmaceuticals · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 6, 2026
$13,91
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$9,28mínimo 52 semanas
$20,22máximo 52 semanas
Capitalización Bursátil (MRQ)
$1.98B
P/E
-43.5
BPA
$-0.32
tus insignias
Rango 52S
$9–$20
Calificación del Analista
BUY
Precio Objetivo
$28
P/E
-43.5
ROE
-22.4%
Margen de Beneficio Neto
·
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
TRVI Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$13.91
Capitalización Bursátil (MRQ)
$1.98B
P/E
-43.5
BPA
$-0.32
ROE
-22.4%
Rango 52S
$9–$20
TRVI Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
BPA$-0.322021-12-31 → 2025-12-31
Flujo de caja libre$-42M2019-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | TRVI | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E | -43.5promedio 5A ≈-11.5 | ≈-11.5 | · | · | |
| P/C (MRQ) | 6.2promedio 5A ≈3.2 | ≈3.2 | 3.4 | Sobrevalorado | |
| Precio / FCF (TTM) | -37.5promedio 5A ≈-13.8 | ≈-13.8 | · | · | |
| Precio / Flujo de Caja (TTM) | -37.6promedio 5A ≈-11.2 | ≈-11.2 | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 9.7promedio 5A ≈3.2 | ≈3.2 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | TRVI | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| ROA | -28.1%promedio 5A ≈-43.7% | ≈-43.7% | -3.6% | Débil | |
| ROE | -22.4%promedio 5A ≈-76.4% | ≈-76.4% | -16.4% | Por debajo del promedio | |
| ROIC | -26.9%promedio 5A ≈-67.5% | ≈-67.5% | -10.3% | Débil |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | TRVI | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 37.3promedio 5A ≈11.4 | ≈11.4 | 4.7 | Liquidez sólida | |
| Quick Ratio (Ratio Rápido) | 19.3promedio 5A ≈11.1 | ≈11.1 | 3.4 | Liquidez sólida |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
13.7%
Próximo informe
Nov 11, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 5, 2026 | $-0.11 | $-0.11 | 2.2% |
| 31 de marzo de 2026 | $-0.09 | $-0.08 | -15.4% | |
| 31 de diciembre de 2025 | $-0.06 | $-0.10 | 40.1% | |
| 30 de septiembre de 2025 | $-0.08 | $-0.10 | 20.2% | |
| 30 de junio de 2025 | $-0.09 | $-0.10 | 12.6% | |
| 31 de marzo de 2025 | $-0.09 | $-0.12 | 27.1% | |
| 31 de diciembre de 2024 | $-0.11 | $-0.12 | 9.3% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $33M | $39M | $24M | $20M | $23M | $22M | $19M | $14M | |
| SG&A Expense | $16M | $12M | $10M | $10M | $9M | $10M | $7M | $4M | |
| Operating Expenses | $49M | $52M | $34M | $30M | $32M | $32M | $27M | $18M | |
| Operating Income | $-49M | $-52M | $-34M | $-30M | $-32M | $-32M | $-27M | $-18M | |
| Interest Expense | · | · | $391.0K | $1M | $1M | $456.0K | · | $174.0K | |
| Interest Income | $7M | $4M | $5M | · | · | · | · | · | |
| Other Non-op | $-31.0K | $-15.0K | $469.0K | $289.0K | $-375.0K | $-287.0K | $577.0K | $-2M | |
| Pretax Income | $-43M | $-48M | $-29M | $-29M | $-34M | $-33M | $-26M | $-21M | |
| Income Tax | $-64.0K | $-30.0K | $-32.0K | $-36.0K | $-21.0K | $-18.0K | $-18.0K | $-124.0K | |
| Net Income | $-43M | $-48M | $-29M | $-29M | $-34M | $-33M | $-26M | $-21M | |
| EPS (Basic) | $-0.32 | $-0.47 | $-0.29 | $-0.45 | $-1.49 | · | · | · | |
| EPS (Diluted) | $-0.32 | $-0.47 | $-0.29 | $-0.45 | $-1.49 | · | · | · | |
| Shares (Basic) | 134,747,198 | 101,971,873 | 99,033,373 | 64,541,911 | 22,841,481 | · | · | · | |
| Shares (Diluted) | 134,747,198 | 101,971,873 | 99,033,373 | 64,541,911 | 22,841,481 | · | · | · | |
| EBITDA | $-49M | $-51M | $-34M | $-30M | $-32M | $-32M | $-27M | · |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $19M | $34M | $32M | $13M | $37M | $45M | $57M | $7M | |
| Short-term Investments | $169M | $74M | $51M | $108M | · | · | · | · | |
| Prepaid Expense | $1M | $939.0K | $4M | $795.0K | $886.0K | $1M | $2M | $1M | |
| Other Current Assets | $2M | $867.0K | $955.0K | $1M | $241.0K | $265.0K | · | · | |
| Current Assets | $192M | $109M | $88M | $123M | $38M | $46M | $60M | $9M | |
| PP&E (Net) | $178.0K | $157.0K | $216.0K | $170.0K | $53.0K | $103.0K | $118.0K | $149.0K | |
| PP&E (Gross) | $537.0K | $385.0K | $350.0K | $395.0K | $235.0K | $235.0K | $203.0K | $195.0K | |
| Accum. Depreciation | $359.0K | $228.0K | $134.0K | $225.0K | $182.0K | $132.0K | $85.0K | $46.0K | |
| Other Non-current Assets | $928.0K | $243.0K | $297.0K | $205.0K | $334.0K | $532.0K | · | · | |
| Total Assets | $193M | $111M | $89M | $123M | $38M | $47M | $60M | $11M | |
| Accounts Payable | $4M | $3M | $2M | $3M | $3M | $2M | $2M | $603.0K | |
| Accrued Liabilities | $6M | $7M | $4M | $4M | $4M | $3M | $4M | $2M | |
| Current Liabilities | $10M | $11M | $6M | $13M | $13M | $6M | $5M | $3M | |
| Capital Leases | $446.0K | $747.0K | $1M | $2.0K | $24.0K | $144.0K | $257.0K | $46.0K | |
| Other Non-current Liabilities | · | · | · | $3.0K | · | · | · | · | |
| Total Liabilities | $10M | $11M | $7M | $16M | $21M | $20M | · | · | |
| Common Stock | $128.0K | $94.0K | $68.0K | $60.0K | $29.0K | $19.0K | $18.0K | $4.0K | |
| Paid-in Capital | $513M | $387M | $322M | $318M | $198M | $174M | $169M | · | |
| Retained Earnings | $-330M | $-287M | $-239M | $-210M | $-181M | $-147M | $-114M | $-109M | |
| AOCI | $148.0K | $61.0K | $-29.0K | $-122.0K | · | · | · | · | |
| Stockholders' Equity | $183M | $100M | $83M | $107M | $17M | $27M | $55M | $-109M | |
| Liabilities + Equity | $193M | $111M | $89M | $123M | $38M | $47M | $60M | $11M | |
| Shares Outstanding | 128,306,056 | 93,602,631 | 68,283,699 | 59,943,430 | 28,505,804 | 18,546,786 | 17,834,570 | 438,600 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $144.0K | $147.0K | $123.0K | $43.0K | · | · | · | · | |
| Stock-based Comp | $5M | $4M | $2M | $2M | $3M | $2M | $1M | $496.0K | |
| Other Non-cash | $-5M | $6M | $-5M | · | · | · | · | · | |
| Operating Cash Flow | $-42M | $-38M | $-32M | $-28M | $-29M | $-29M | $-23M | $-18M | |
| CapEx | $12.0K | $35.0K | $137.0K | $159.0K | · | $32.0K | $9.0K | $158.0K | |
| Investing Cash Flow | $-94M | $-22M | $59M | $-107M | · | $-32.0K | $-9.0K | $-158.0K | |
| Debt Issued | · | · | · | · | · | $14M | · | · | |
| Net Debt Issued | · | · | · | $-6M | · | $14M | · | · | |
| Financing Cash Flow | $121M | $61M | $-8M | $111M | $21M | $17M | $73M | $4M | |
| Net Change in Cash | $-15M | $2M | $20M | $-24M | $-8M | $-12M | $50M | $-15M | |
| Taxes Paid | $-33.0K | $-32.0K | · | · | · | · | · | · | |
| Free Cash Flow | $-42M | $-38M | $-32M | $-28M | · | $-29M | $-23M | · | |
| Levered FCF | · | · | $-32M | $-29M | · | $-29M | · | · |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| ROA | -28.1% | -47.8% | -27.4% | -36.1% | -79.3% | -61.2% | -73.9% | · | |
| ROE | -22.4% | -60.4% | -33.8% | -26.8% | -238.5% | -104.2% | -45.2% | · | |
| ROIC | -26.9% | -51.7% | -41.0% | -27.8% | -190.1% | -119.0% | -48.8% | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 19.7 | 10.4 | 15.0 | 9.2 | 3.0 | 8.3 | 11.5 | · | |
| Quick Ratio | 19.3 | 10.2 | 14.2 | 9.0 | 2.9 | 8.1 | 11.0 | · | |
| Interest Coverage | · | · | -86.8 | -25.7 | -27.0 | -71.2 | · | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.43 | $1.06 | $1.21 | $1.79 | $0.60 | $1.47 | $3.06 | · | |
| Cash Flow / Share | $-0.31 | $-0.38 | $-0.32 | $-0.44 | · | · | · | · | |
| Cash / Share | $0.15 | $0.36 | $0.47 | $0.21 | $1.29 | $2.43 | $3.21 | · | |
| EPS (TTM) | $-0.32 | $-0.47 | $-0.29 | $-0.45 | $-1.49 | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-43M | $-48M | $-29M | $-29M | $-34M | $-33M | $-26M | · | |
| Market Cap | $1.61B | $386M | $92M | $116M | $22M | $45M | $67M | · | |
| P/E | -39.1 | -8.8 | -4.6 | -4.3 | -0.5 | · | · | · | |
| P/B | 8.8 | 3.9 | 1.1 | 1.1 | 1.3 | 1.6 | 1.2 | · | |
| P / Tangible Book | 8.8 | 3.9 | 1.1 | 1.1 | 1.3 | 1.6 | · | · | |
| P / Cash Flow | -38.2 | -10.1 | -2.9 | -4.1 | -0.8 | -1.5 | -2.9 | · | |
| P / FCF | -38.2 | -10.1 | -2.9 | -4.1 | · | -1.5 | -2.9 | · | |
| Earnings Yield | -2.6% | -11.4% | -21.6% | -23.3% | -190.5% | · | · | · |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $15M | $10M | $6M | $10M | $9M | $8M | $9M | $11M | $10M | $9M | $7M | $6M | $6M | $5M | $4M | $6M | |
| SG&A Expense | $5M | $5M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $2M | $3M | $3M | $3M | $2M | $3M | |
| Operating Expenses | $21M | $15M | $10M | $14M | $14M | $11M | $12M | $14M | $13M | $12M | $9M | $9M | $8M | $8M | $7M | $8M | |
| Operating Income | $-21M | $-15M | $-10M | $-14M | $-14M | $-11M | $-12M | $-14M | $-13M | $-12M | $-9M | $-9M | $-8M | $-8M | $-7M | $-8M | |
| Interest Expense | · | · | · | · | · | · | · | · | $1.0K | $1.0K | · | $3.0K | $153.0K | $231.0K | $274.0K | $292.0K | |
| Interest Income | $3M | $2M | $2M | $2M | $1M | $1M | $843.0K | $826.0K | $935.0K | $998.0K | $1M | $1M | · | · | · | · | |
| Other Non-op | $-3.0K | $4.0K | $-16.0K | $-2.0K | $-7.0K | $-6.0K | $2.0K | $-11.0K | $-5.0K | $-1.0K | $-3.0K | $154.0K | $153.0K | $165.0K | $702.0K | $132.0K | |
| Pretax Income | $-18M | $-13M | $-8M | $-12M | $-12M | $-10M | $-11M | $-13M | $-12M | $-11M | $-8M | $-8M | $-7M | $-6M | $-6M | $-8M | |
| Income Tax | $-19.0K | $-20.0K | $-17.0K | $-15.0K | $-21.0K | $-11.0K | $17.0K | $-31.0K | $-8.0K | $-8.0K | $18.0K | $-13.0K | $-30.0K | $-7.0K | $-20.0K | $-7.0K | |
| Net Income | $-18M | $-13M | $-8M | $-12M | $-12M | $-10M | $-11M | $-13M | $-12M | $-11M | $-8M | $-8M | $-7M | $-6M | $-6M | $-8M | |
| EPS (Basic) | $-0.11 | $-0.09 | $-0.06 | $-0.08 | $-0.09 | $-0.09 | $-0.11 | $-0.13 | $-0.12 | $-0.11 | $-0.08 | $-0.08 | $-0.07 | $-0.06 | $0.05 | $-0.12 | |
| EPS (Diluted) | $-0.11 | $-0.09 | $-0.06 | $-0.08 | $-0.09 | $-0.09 | $-0.11 | $-0.13 | $-0.12 | $-0.11 | $-0.08 | $-0.08 | $-0.07 | $-0.06 | $0.05 | $-0.12 | |
| Shares (Basic) | 156,602,158 | 145,592,901 | · | 145,104,986 | 130,350,391 | 117,610,750 | · | 101,282,228 | 101,041,573 | 99,517,212 | · | 99,325,540 | 98,698,579 | 98,610,671 | · | 68,898,810 | |
| Shares (Diluted) | 156,602,158 | 145,592,901 | · | 145,104,986 | 130,350,391 | 117,610,750 | · | 101,282,228 | 101,041,573 | 99,517,212 | · | 99,325,540 | 98,698,579 | 98,610,671 | · | 68,898,810 | |
| EBITDA | $-21M | $-15M | · | $-14M | $-14M | $-11M | · | $-14M | $-13M | $-12M | · | $-9M | $-8M | $-8M | · | $-8M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $54M | $19M | $19M | $57M | $117M | $19M | $34M | $16M | $13M | $14M | $32M | $26M | $14M | $12M | $13M | $67M | |
| Short-term Investments | $265M | $152M | $169M | $138M | $87M | $84M | $74M | $49M | $57M | $59M | $51M | $63M | $80M | $100M | $108M | $59M | |
| Prepaid Expense | $4M | $2M | $1M | $1M | $2M | $2M | $939.0K | $1M | $2M | $3M | $4M | $4M | $3M | $1M | $795.0K | $1M | |
| Other Current Assets | $3M | $2M | $2M | $2M | $2M | $834.0K | $867.0K | $667.0K | $830.0K | $721.0K | $955.0K | $1M | $2M | $2M | $1M | $421.0K | |
| Current Assets | $326M | $176M | $192M | $198M | $207M | $106M | $109M | $67M | $72M | $77M | $88M | $94M | $99M | $114M | $123M | $127M | |
| PP&E (Net) | $336.0K | $265.0K | $178.0K | $213.0K | $239.0K | $277.0K | $157.0K | $174.0K | $198.0K | $204.0K | $216.0K | $238.0K | $225.0K | $245.0K | $170.0K | $68.0K | |
| PP&E (Gross) | · | · | $537.0K | · | · | · | $385.0K | · | · | · | $350.0K | · | · | · | $395.0K | · | |
| Accum. Depreciation | · | · | $359.0K | · | · | · | $228.0K | · | · | · | $134.0K | · | · | · | $225.0K | · | |
| Other Non-current Assets | $4M | $3M | $928.0K | $103.0K | $68.0K | $241.0K | $243.0K | $256.0K | $273.0K | $311.0K | $297.0K | $297.0K | $68.0K | $225.0K | $205.0K | $922.0K | |
| Total Assets | $331M | $180M | $193M | $199M | $208M | $107M | $111M | $69M | $74M | $79M | $89M | $96M | $101M | $116M | $123M | $128M | |
| Accounts Payable | $3M | $2M | $4M | $3M | $3M | $1M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $3M | $2M | |
| Accrued Liabilities | $5M | $5M | $6M | $6M | $6M | $5M | $7M | $7M | $5M | $3M | $4M | $4M | $3M | $3M | $4M | $5M | |
| Current Liabilities | $9M | $7M | $10M | $9M | $9M | $7M | $11M | $9M | $7M | $5M | $6M | $5M | $5M | $13M | $13M | $15M | |
| Capital Leases | $276.0K | $364.0K | $446.0K | $527.0K | $605.0K | $681.0K | $747.0K | $816.0K | $884.0K | $949.0K | $1M | $1M | $1M | $1M | $2.0K | $2.0K | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $3.0K | $15.0K | |
| Total Liabilities | $9M | $7M | $10M | $10M | $10M | $8M | $11M | $10M | $8M | $6M | $7M | $6M | $6M | $14M | $16M | $18M | |
| Common Stock | $142.0K | $128.0K | $128.0K | $128.0K | $122.0K | $100.0K | $94.0K | $75.0K | $73.0K | $69.0K | $68.0K | $64.0K | $63.0K | $60.0K | $60.0K | $58.0K | |
| Paid-in Capital | $683M | $515M | $513M | $511M | $508M | $397M | $387M | $334M | $329M | $322M | $322M | $321M | $319M | $318M | $318M | $315M | |
| Retained Earnings | $-361M | $-343M | $-330M | $-321M | $-310M | $-297M | $-287M | $-276M | $-262M | $-250M | $-239M | $-231M | $-224M | $-216M | $-210M | $-205M | |
| AOCI | $-425.0K | $-190.0K | $148.0K | $30.0K | $24.0K | $73.0K | $61.0K | $139.0K | $-84.0K | $-67.0K | $-29.0K | $-217.0K | $-248.0K | $-88.0K | $-122.0K | $-263.0K | |
| Stockholders' Equity | $322M | $172M | $183M | $190M | $198M | $99M | $100M | $59M | $66M | $72M | $83M | $90M | $95M | $102M | $107M | $110M | |
| Liabilities + Equity | $331M | $180M | $193M | $199M | $208M | $107M | $111M | $69M | $74M | $79M | $89M | $96M | $101M | $116M | $123M | $128M | |
| Shares Outstanding | 142,420,883 | 128,411,048 | 128,306,056 | 128,215,113 | 121,775,753 | 99,892,915 | 93,602,631 | 75,454,375 | 72,591,917 | 68,960,167 | 68,283,699 | 63,855,330 | 63,098,455 | 60,065,408 | 59,943,430 | 58,322,517 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $34.0K | $34.0K | $31.0K | $38.0K | $38.0K | $37.0K | $38.0K | $36.0K | $38.0K | $35.0K | $35.0K | $35.0K | $34.0K | $19.0K | $15.0K | $9.0K | |
| Stock-based Comp | $3M | $2M | $1M | $1M | $1M | $1M | $916.0K | $822.0K | $1M | $723.0K | $609.0K | $530.0K | $530.0K | $578.0K | $501.0K | $569.0K | |
| Other Non-cash | · | $-6M | · | · | · | $-4M | · | · | · | $-323.0K | · | · | · | $-2M | · | · | |
| Operating Cash Flow | $-17M | $-17M | $-8M | $-11M | $-10M | $-13M | $-10M | $-10M | $-9M | $-10M | $-6M | $-7M | $-10M | $-8M | $-6M | $-9M | |
| CapEx | $124.0K | $102.0K | $0 | $12.0K | · | · | $7.0K | $0 | · | · | $22.0K | $18.0K | $40.0K | $57.0K | $116.0K | · | |
| Investing Cash Flow | $-112M | $17M | $-31M | $-51M | $-3M | $-10M | $-24M | $8M | $3M | $-8M | $13M | $18M | $20M | $9M | $-48M | $-5M | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | $-2M | · | · | |
| Financing Cash Flow | $164M | $222.0K | $284.0K | $2M | $110M | $9M | $51M | $5M | $5M | $-28.0K | $-54.0K | $2M | $-8M | $-2M | $652.0K | $55M | |
| Net Change in Cash | $35M | $498.0K | $-38M | $-60M | $98M | $-15M | $18M | $3M | $-848.0K | $-19M | $6M | $12M | $2M | $-938.0K | $-54M | $42M | |
| Free Cash Flow | · | $-17M | · | · | · | · | · | · | · | · | · | · | · | $-8M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | · | · | · | $-8M | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -6.6% | -9.2% | · | -8.8% | -8.7% | -11.1% | · | -16.1% | -14.1% | -11.2% | · | -6.9% | -7.8% | -8.7% | · | -10.3% | |
| ROE | -6.9% | -9.7% | · | -9.5% | -9.3% | -12.0% | · | -17.8% | -15.3% | -12.5% | · | -7.7% | -9.2% | -11.4% | · | -13.6% | |
| ROIC | -6.4% | -8.6% | · | -7.3% | -6.9% | -11.5% | · | -23.8% | -20.1% | -16.4% | · | -10.1% | -8.8% | -7.4% | · | -7.6% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 37.3 | 24.8 | · | 21.9 | 22.4 | 15.4 | · | 7.4 | 10.7 | 14.6 | · | 18.2 | 21.1 | 8.7 | · | 8.7 | |
| Quick Ratio | 36.5 | 24.1 | · | 21.6 | 22.1 | 15.0 | · | 7.2 | 10.3 | 13.8 | · | 17.2 | 20.0 | 8.4 | · | 8.6 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -13289.0 | -11906.0 | · | -3015.0 | -54.8 | -32.7 | · | -28.8 |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.26 | $1.34 | · | $1.48 | $1.63 | $1.00 | · | $0.78 | $0.91 | $1.05 | · | $1.40 | $1.51 | $1.69 | · | $1.88 | |
| Cash Flow / Share | · | $-0.11 | · | · | · | $-0.11 | · | · | · | $-0.11 | · | · | · | $-0.08 | · | · | |
| Cash / Share | $0.38 | $0.15 | · | $0.44 | $0.96 | $0.19 | · | $0.21 | $0.18 | $0.20 | · | $0.41 | $0.22 | $0.19 | · | $1.14 | |
| EPS (TTM) | $-0.34 | $-0.32 | · | $-0.37 | $-0.42 | $-0.45 | · | $-0.44 | $-0.39 | $-0.34 | · | $-0.16 | $-0.20 | $-0.27 | · | $-0.74 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-51M | $-46M | · | $-46M | $-47M | $-47M | · | $-44M | $-39M | $-34M | · | $-27M | $-27M | $-28M | · | $-32M | |
| Market Cap | $2.66B | $1.53B | · | $1.17B | $666M | $628M | · | $252M | $216M | $238M | · | $139M | $151M | $111M | · | $90M | |
| P/E | -54.9 | -37.3 | · | -24.7 | -13.0 | -14.0 | · | -7.6 | -7.6 | -10.1 | · | -13.6 | -11.9 | -6.9 | · | -2.1 | |
| P/B | 8.3 | 8.9 | · | 6.2 | 3.4 | 6.3 | · | 4.3 | 3.3 | 3.3 | · | 1.6 | 1.6 | 1.1 | · | 0.8 | |
| P / Tangible Book | 8.3 | 8.9 | · | 6.2 | 3.4 | 6.3 | · | 4.3 | 3.3 | 3.3 | · | 1.6 | 1.6 | 1.1 | · | 0.8 | |
| P / Cash Flow | · | -91.8 | · | · | · | -46.6 | · | · | · | -22.7 | · | · | · | -13.6 | · | · | |
| Earnings Yield | -1.8% | -2.7% | · | -4.0% | -7.7% | -7.1% | · | -13.2% | -13.1% | -9.9% | · | -7.3% | -8.4% | -14.6% | · | -48.0% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Beneficio neto | $-43M | $-48M | $-29M | $-29M | $-34M |
| EPS Diluido | $-0.32 | $-0.47 | $-0.29 | $-0.45 | $-1.49 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio corriente | 19.7 | 10.4 | 15.0 | 9.2 | 3.0 |
| Ratio Rápido | 19.3 | 10.2 | 14.2 | 9.0 | 2.9 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $-42M | $-38M | $-32M | $-28M | · |
Propietarios institucionales (13F) 226 declarantes · $2.8B total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
226
Valor en tenencia
$2.8B
Nuevas posiciones
41
Posiciones cerradas
19
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 41 (-2 vs trimestre anterior) | 19 (-5 vs trimestre anterior) | 89 (+23 vs trimestre anterior) | 61 (-4 vs trimestre anterior) | +13.7M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| NEA Management Company, LLC | $246 594 552 | 13 222 228 | 8,67% | Acciones |
| FMR LLC | $234 296 949 | 12 562 839 | 8,24% | Acciones |
| BlackRock, Inc. | $208 041 234 | 11 155 026 | 7,32% | Acciones |
| Frazier Life Sciences Management, L.P. | $185 370 687 | 9 939 447 | 6,52% | Acciones |
| WELLINGTON MANAGEMENT GROUP LLP | $106 017 642 | 5 684 592 | 3,73% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $103 147 089 | 5 530 675 | 3,63% | Acciones |
| Vivo Capital, LLC | $95 015 558 | 5 094 668 | 3,34% | Acciones |
| VANGUARD GROUP INC | $80 561 880 | 6 434 655 | 2,83% | Acciones |
| Woodline Partners LP | $76 116 860 | 4 081 333 | 2,68% | Acciones |
| Vestal Point Capital, LP | $57 815 000 | 3 100 000 | 2,03% | Acciones |
| MPM BIOIMPACT LLC | $57 322 211 | 3 073 577 | 2,02% | Acciones |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $57 269 301 | 3 070 740 | 2,01% | Acciones |
| STATE STREET CORP | $56 459 425 | 3 027 315 | 1,99% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $54 619 528 | 2 928 068 | 1,92% | Acciones |
| MARSHALL WACE, LLP | $49 872 655 | 2 674 137 | 1,75% | Acciones |
| EVENTIDE ASSET MANAGEMENT, LLC | $49 609 000 | 2 660 000 | 1,74% | Acciones |
| Rubric Capital Management LP | $46 709 167 | 2 504 513 | 1,64% | Acciones |
| Artia Global Partners LP | $41 232 390 | 2 210 852 | 1,45% | Acciones |
| ACORN CAPITAL ADVISORS, LLC | $40 001 341 | 2 144 844 | 1,41% | Acciones |
| First Light Asset Management, LLC | $39 113 060 | 2 097 215 | 1,38% | Acciones |
| Pictet Asset Management Holding SA | $37 557 109 | 2 013 786 | 1,32% | Acciones |
| Logos Global Management LP | $35 062 000 | 1 880 000 | 1,23% | Acciones |
| Affinity Asset Advisors, LLC | $33 573 208 | 1 800 172 | 1,18% | Acciones |
| EMERALD ADVISERS, LLC | $33 525 445 | 1 797 611 | 1,18% | Acciones |
| Siren, L.L.C. | $33 325 070 | 1 786 867 | 1,17% | Acciones |
| Pivotal bioVenture Partners Investment Advisor LLC | $32 500 833 | 1 742 672 | 1,14% | Acciones |
| RAYMOND JAMES FINANCIAL INC | $30 038 753 | 1 610 657 | 1,06% | Acciones |
| VIKING GLOBAL INVESTORS LP | $28 807 611 | 1 544 644 | 1,01% | Acciones |
| BANK OF AMERICA CORP /DE/ | $28 588 381 | 1 532 889 | 1,01% | Acciones |
| Assenagon Asset Management S.A. | $28 447 106 | 1 525 314 | 1,00% | Acciones |
| ALLIANCEBERNSTEIN L.P. | $28 100 554 | 2 355 453 | 0,99% | Acciones |
| ORBIMED ADVISORS LLC | $26 674 964 | 1 430 293 | 0,94% | Acciones |
| Jones Hill Capital LP | $24 976 304 | 1 339 212 | 0,88% | Acciones |
| NAN FUNG TRINITY (HK) LTD | $22 634 013 | 1 213 620 | 0,80% | Acciones |
| EMERALD MUTUAL FUND ADVISERS TRUST | $22 584 497 | 1 210 965 | 0,79% | Acciones |
| GOLDMAN SACHS GROUP INC | $22 426 998 | 1 202 520 | 0,79% | Acciones |
| Soleus Capital Management, L.P. | $21 999 876 | 1 179 618 | 0,77% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $21 948 663 | 1 176 872 | 0,77% | Acciones |
| BARCLAYS PLC | $21 299 737 | 1 142 077 | 0,75% | Acciones |
| Saturn V Capital Management LP | $19 620 602 | 1 052 043 | 0,69% | Acciones |
| FLPUTNAM INVESTMENT MANAGEMENT CO | $19 359 763 | 1 038 057 | 0,68% | Acciones |
| NORTHERN TRUST CORP | $18 762 609 | 1 006 038 | 0,66% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $18 138 990 | 972 600 | 0,64% | Opción de compra |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $18 004 747 | 965 402 | 0,63% | Acciones |
| Candriam S.C.A. | $18 002 647 | 966 219 | 0,63% | Acciones |
| Balyasny Asset Management L.P. | $15 760 873 | 845 087 | 0,55% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $15 685 750 | 841 059 | 0,55% | Acciones |
| MORGAN STANLEY | $14 928 673 | 800 465 | 0,53% | Acciones |
| Nuveen, LLC | $14 270 533 | 765 176 | 0,50% | Acciones |
| Burkehill Global Management, LP | $13 521 250 | 725 000 | 0,48% | Acciones |
Activistas y propietarios del %+ 5 2 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| New Enterprise Associates 16, L.P., NEA Partners 16, L.P., NEA 16 GP, LLC, NEA 18 Venture Growth Equity, L.P., NEA Partners 18 VGE, L.P., NEA 18 VGE GP, LLC, Forest Baskett, Ali Behbahani, Carmen Chang, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Scott D. Sandell, Paul Walker ×10 presentaciones | 7 de mayo de 2026 | 10,50% | Enmienda | Inversión pasiva | SEC |
| Omega Fund V, L.P., Omega Fund V GP, L.P., Omega Fund V GP Manager, Ltd., Richard J. Lim, Claudio Nessi, Anne-Mari Paster, Otello Stampacchia | 20 de mayo de 2019 | · | Presentación inicial | Campaña de la junta directiva | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 37 insiders · 13 directivos · 9 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Jennifer L Good | President & CEO | 19 de febrero de 2026 A | 213 313 | 0 | 0 | $0 |
| David C Hastings | Chief Financial Officer | 8 de enero de 2026 A | · | 0 | 0 | $0 |
| Lisa Delfini | Chief Financial Officer | 31 de mayo de 2025 A | 64 660 | 0 | 0 | $0 |
| Christopher Seiter | Chief Financial Officer | 17 de febrero de 2021 A | · | 0 | 0 | $0 |
| Farrell Simon | Chief Commercial Officer | 19 de febrero de 2026 A | 76 900 | 0 | 0 | $0 |
| Christopher Galletta | Controller and Principal Accounting Officer | 19 de febrero de 2026 A | 26 095 | 0 | 0 | $0 |
| James V Cassella | Chief Development Officer | 19 de febrero de 2026 A | · | 0 | 0 | $0 |
| Thomas Sciascia | Chief Scientific Officer | 19 de febrero de 2026 A | 221 373 | 0 | 0 | $0 |
| David J Clark | Chief Medical Officer | 15 de febrero de 2024 A | · | 0 | 0 | $0 |
| William P Forbes | Chief Development Officer | 29 de junio de 2022 A | · | 0 | 0 | $0 |
| Frank P Muscolo | Controller | 17 de febrero de 2021 A | · | 0 | 0 | $0 |
| Helena Brett-Smith | Chief Development Officer | 13 de febrero de 2020 A | · | 0 | 0 | $0 |
| Yann Mazabraud | Chief Commercial Officer and Head of International | 13 de febrero de 2020 A | · | 0 | 0 | $0 |
| Michael Thomas Heffernan | Consejero | 15 de septiembre de 2026 M | 6 351 | 0 | 4 | $-595 806 |
| David P Meeker | Consejero | 3 de junio de 2026 A | 352 489 | 0 | 0 | $0 |
| Edward T. Mathers | Consejero | 3 de junio de 2026 A | 948 948 | 0 | 0 | $0 |
| Dominick Colangelo | Consejero | 3 de junio de 2026 A | · | 0 | 0 | $0 |
| Anne Vanlent | Consejero | 3 de junio de 2026 A | 25 983 | 0 | 0 | $0 |
| Mette Kirstine Agger | Consejero | 9 de mayo de 2019 C | 1 151 544 | 0 | 0 | $0 |
| Anna Guyer Mitsak | Consejero | 7 de mayo de 2019 A | · | 0 | 0 | $0 |
| Eran Nadav | Consejero | 7 de mayo de 2019 A | · | 0 | 0 | $0 |
| Mohamad Makhzoumi | Propietario del 10% | 11 de abril de 2022 P | 948 948 | 0 | 0 | $0 |
| Ali Behbahani | Propietario del 10% | 11 de abril de 2022 P | 948 948 | 0 | 0 | $0 |
| Anthony A. Florence, Jr. | Propietario del 10% | 11 de abril de 2022 P | 948 948 | 0 | 0 | $0 |
| Peter W. Sonsini | Propietario del 10% | 11 de abril de 2022 P | 948 948 | 0 | 0 | $0 |
| Paul Walker | Propietario del 10% | 11 de abril de 2022 P | 948 948 | 0 | 0 | $0 |
| Forest Baskett | Propietario del 10% | 11 de abril de 2022 P | 10 421 428 | 0 | 0 | $0 |
| Scott D. Sandell | Propietario del 10% | 11 de abril de 2022 P | 948 948 | 0 | 0 | $0 |
| Joshua Makower | Propietario del 10% | 3 de abril de 2020 X | 5 937 998 | 0 | 0 | $0 |
| Debra A Drake | Propietario del 10% | 9 de mayo de 2019 C | 10 399 | 0 | 0 | $0 |
| Richard King Mellon Foundation | Propietario del 10% | 9 de mayo de 2019 C | 347 157 | 0 | 0 | $0 |
| Lundbeckfond Invest A/S | Propietario del 10% | 9 de mayo de 2019 C | 1 151 544 | 0 | 0 | $0 |
| Peter F Drake | Propietario del 10% | 9 de mayo de 2019 C | 62 540 | 0 | 0 | $0 |
| William J Oshea | Propietario del 10% | 9 de mayo de 2019 C | 114 080 | 0 | 0 | $0 |
| David M Mott | Propietario del 10% | 9 de mayo de 2019 C | 4 438 562 | 0 | 0 | $0 |
| Peter J Barris | Propietario del 10% | 9 de mayo de 2019 C | 4 438 562 | 0 | 0 | $0 |
| Carmen Chang | · | 11 de abril de 2022 P | 948 948 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 24 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| PILL · Direxion Shares ETF Trust | 1,55% | 17 529 NS | 31 de julio de 2026 | N-PORT |
| PTH · Invesco Exchange-Traded Fund Trust | 0,88% | 224 707 SH | 1 de octubre de 2026 | Diario |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0,59% | 166 997 SH | 1 de octubre de 2026 | Diario |
| IHE · iShares Trust | 0,43% | 436 183 SH | 11 de septiembre de 2026 | Diario |
| VFMO · VANGUARD WELLINGTON FUND | 0,14% | 148 479 SH | 19 de agosto de 2026 | Diario |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,13% | 10 058 SH | 1 de octubre de 2026 | Diario |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,12% | 114 901 SH | 19 de agosto de 2026 | Diario |
| IWO · iShares Trust | 0,11% | 1 007 147 SH | 11 de septiembre de 2026 | Diario |
| IBB · iShares Trust | 0,11% | 707 885 SH | 11 de septiembre de 2026 | Diario |
| RSSL · Global X Funds | 0,06% | 51 308 NS | 31 de julio de 2026 | N-PORT |
| ISCG · iShares Trust | 0,06% | 37 734 SH | 11 de septiembre de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,06% | 616 796 SH | 19 de agosto de 2026 | Diario |
| IWM · iShares Trust | 0,06% | 2 737 721 SH | 11 de septiembre de 2026 | Diario |
| ESML · iShares Trust | 0,05% | 81 532 SH | 11 de septiembre de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | 0,03% | 287 822 SH | 19 de agosto de 2026 | Diario |
| FHLC · FIDELITY COVINGTON TRUST | 0,03% | 45 551 NS | 31 de julio de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 1 352 952 SH | 19 de agosto de 2026 | Diario |
| WSML · iShares Trust | 0,01% | 5 214 SH | 11 de septiembre de 2026 | Diario |
| TILT · FlexShares Trust | 0,00% | 3 318 NS | 31 de julio de 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 152 436 SH | 11 de septiembre de 2026 | Diario |
| IWV · iShares Trust | 0,00% | 24 754 SH | 9 de septiembre de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 4 048 595 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 8 874 SH | 19 de agosto de 2026 | Diario |
| ISCB · iShares Trust | · | 5 335 SH | 11 de septiembre de 2026 | Diario |
TRVI Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 18 analistas
COMPRA
Objetivo mediano
$25.00
+79,7%
6 33,3%
Compra fuerte
11 61,1%
Compra
1 5,6%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
11 analistas · 2026-09-27Objetivo medio $28.18 +102,6%
← Por Debajo de Todos los Objetivos
Precio Actual $13.91
Mín$23.00
Media$28.18
Máx$40.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| TRVI | $1.61B | -39.1 | · | · | -22.4% | · |
| HRMY | $2.16B | 13.8 | 21.5% | 18.3% | 19.3% | 77.2% |
| PBH | $3.33B | 15.2 | -4.3% | 17.5% | 10.2% | 54.7% |
| GPCR | $14.78B | -86.9 | · | · | -12.3% | · |
| TRLV | · | · | -0.45% | -10.3% | -10.4% | 60.2% |
| NUVB | $3.03B | -14.9 | 699.0% | -325.3% | -60.3% | · |
| SEPN | $1.25B | -25.3 | 4174.5% | -106.4% | -12.9% | · |
| ANIP | $1.78B | 23.8 | 43.8% | 8.9% | 16.6% | · |
| ETON | $457M | · | 104.9% | -5.8% | -18.4% | 53.5% |
| RAPP | $1.45B | -10.6 | · | · | -29.8% | · |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 6, 2026